Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells
In chronic kidney disease, hyperphosphatemia is a key pathological factor promoting medial vascular calcification, a common complication associated with cardiovascular events and mortality. This active pathophysiological process involves osteo-/chondrogenic transdifferentiation of vascular smooth mu...
Gespeichert in:
Veröffentlicht in: | Journal of molecular medicine (Berlin, Germany) Germany), 2020-07, Vol.98 (7), p.985-997 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 997 |
---|---|
container_issue | 7 |
container_start_page | 985 |
container_title | Journal of molecular medicine (Berlin, Germany) |
container_volume | 98 |
creator | Alesutan, Ioana Moritz, Franco Haider, Tatjana Shouxuan, Sun Gollmann-Tepeköylü, Can Holfeld, Johannes Pieske, Burkert Lang, Florian Eckardt, Kai-Uwe Heinzmann, Silke Sophie Voelkl, Jakob |
description | In chronic kidney disease, hyperphosphatemia is a key pathological factor promoting medial vascular calcification, a common complication associated with cardiovascular events and mortality. This active pathophysiological process involves osteo-/chondrogenic transdifferentiation of vascular smooth muscle cells (VSMCs) via complex intracellular mechanisms that are still incompletely understood. Little is known about the effects of phosphate on the bioenergetic profile of VSMCs during the onset of this process. Therefore, the present study explored the effects of the phosphate donor β-glycerophosphate on cellular bioenergetics of VSMCs. Mitochondrial and glycolytic functions were determined utilizing extracellular flux analysis in primary human aortic VSMCs following exposure to β-glycerophosphate. In VSMCs, β-glycerophosphate increased basal respiration, mitochondrial ATP production as well as proton leak and decreased spare respiratory capacity and coupling efficiency, but did not modify non-mitochondrial or maximal respiration. β-Glycerophosphate-treated VSMCs had higher ability to increase mitochondrial glutamine and long-chain fatty acid usage as oxidation substrates to meet their energy demand. β-Glycerophosphate did not modify glycolytic function or basal and glycolytic proton efflux rate. In contrast, β-glycerophosphate increased non-glycolytic acidification. β-Glycerophosphate-treated VSMCs had a more oxidative and less glycolytic phenotype, but a reduced ability to respond to stressed conditions via mitochondrial respiration. Moreover, compounds targeting components of mitochondrial respiration modulated β-glycerophosphate-induced oxidative stress, osteo-/chondrogenic signalling and mineralization of VSMCs. In conclusion, β-glycerophosphate modifies key parameters of mitochondrial function and cellular bioenergetics in VSMCs that may contribute to the onset of phenotypical transdifferentiation and calcification. These observations advance the understanding of the role of energy metabolism in VSMC physiology and pathophysiology of vascular calcification during hyperphosphatemia.
Key messages
β-Glycerophosphate modifies key parameters of mitochondrial respiration in VSMCs.
β-Glycerophosphate induces changes in mitochondrial fuel choice in VSMCs.
β-Glycerophosphate promotes a more oxidative and less glycolytic phenotype of VSMCs.
β-Glycerophosphate triggers mitochondrial-dependent oxidative stress in VSMCs.
Bioenergetics impact β-glycerophosphate-induc |
doi_str_mv | 10.1007/s00109-020-01925-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7343738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2421245302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-605c7ae72cd7fe13bb169f95baf8fc60c0f04426c66c9410ea0daa229879b793</originalsourceid><addsrcrecordid>eNp9kc9q3DAQh0VoSLZJXiAnQ89KR38sWZdCCG0TWOgll5yErB2tvdiWK9kLea0-SJ-p3uzS0EtPc5jv983Aj5BbBncMQH_OAAwMBQ4UmOElrc7IiknBKZMSPpAVGKko10xdko857xZcl0ZekEvBZVWVUq3Iy1M_Oj8VMRS_f9Ft9-oxxbGJeWzchEUciqnBom4jDpi2OLW-GFMMbYeHyN5lP3cuFbmPcWqKfs5-2XjsunxNzoPrMt6c5hV5_vb1-eGRrn98f3q4X1MvSzZRBaXXDjX3Gx2QibpmygRT1i5UwSvwEEBKrrxS3kgG6GDjHOem0qbWRlyRL0ftONc9bjwOU3KdHVPbu_Rqo2vtv5uhbew27q0WUmhRLYJPJ0GKP2fMk93FOQ3Ly5ZLzrgsBfCF4kfKp5hzwvD3AgN7aMMe27BLG_atDXtQi2MoL_CwxfSu_k_qDznnjkA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2421245302</pqid></control><display><type>article</type><title>Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells</title><source>Springer Nature - Complete Springer Journals</source><creator>Alesutan, Ioana ; Moritz, Franco ; Haider, Tatjana ; Shouxuan, Sun ; Gollmann-Tepeköylü, Can ; Holfeld, Johannes ; Pieske, Burkert ; Lang, Florian ; Eckardt, Kai-Uwe ; Heinzmann, Silke Sophie ; Voelkl, Jakob</creator><creatorcontrib>Alesutan, Ioana ; Moritz, Franco ; Haider, Tatjana ; Shouxuan, Sun ; Gollmann-Tepeköylü, Can ; Holfeld, Johannes ; Pieske, Burkert ; Lang, Florian ; Eckardt, Kai-Uwe ; Heinzmann, Silke Sophie ; Voelkl, Jakob</creatorcontrib><description>In chronic kidney disease, hyperphosphatemia is a key pathological factor promoting medial vascular calcification, a common complication associated with cardiovascular events and mortality. This active pathophysiological process involves osteo-/chondrogenic transdifferentiation of vascular smooth muscle cells (VSMCs) via complex intracellular mechanisms that are still incompletely understood. Little is known about the effects of phosphate on the bioenergetic profile of VSMCs during the onset of this process. Therefore, the present study explored the effects of the phosphate donor β-glycerophosphate on cellular bioenergetics of VSMCs. Mitochondrial and glycolytic functions were determined utilizing extracellular flux analysis in primary human aortic VSMCs following exposure to β-glycerophosphate. In VSMCs, β-glycerophosphate increased basal respiration, mitochondrial ATP production as well as proton leak and decreased spare respiratory capacity and coupling efficiency, but did not modify non-mitochondrial or maximal respiration. β-Glycerophosphate-treated VSMCs had higher ability to increase mitochondrial glutamine and long-chain fatty acid usage as oxidation substrates to meet their energy demand. β-Glycerophosphate did not modify glycolytic function or basal and glycolytic proton efflux rate. In contrast, β-glycerophosphate increased non-glycolytic acidification. β-Glycerophosphate-treated VSMCs had a more oxidative and less glycolytic phenotype, but a reduced ability to respond to stressed conditions via mitochondrial respiration. Moreover, compounds targeting components of mitochondrial respiration modulated β-glycerophosphate-induced oxidative stress, osteo-/chondrogenic signalling and mineralization of VSMCs. In conclusion, β-glycerophosphate modifies key parameters of mitochondrial function and cellular bioenergetics in VSMCs that may contribute to the onset of phenotypical transdifferentiation and calcification. These observations advance the understanding of the role of energy metabolism in VSMC physiology and pathophysiology of vascular calcification during hyperphosphatemia.
Key messages
β-Glycerophosphate modifies key parameters of mitochondrial respiration in VSMCs.
β-Glycerophosphate induces changes in mitochondrial fuel choice in VSMCs.
β-Glycerophosphate promotes a more oxidative and less glycolytic phenotype of VSMCs.
β-Glycerophosphate triggers mitochondrial-dependent oxidative stress in VSMCs.
Bioenergetics impact β-glycerophosphate-induced VSMC calcification.</description><identifier>ISSN: 0946-2716</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/s00109-020-01925-8</identifier><identifier>PMID: 32488546</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Acidification ; Aorta ; b-Glycerophosphoric acid ; Bioenergetics ; Biomedical and Life Sciences ; Biomedicine ; Calcification ; Calcification (ectopic) ; Cardiovascular diseases ; Electron transport ; Energy metabolism ; Glutamine ; Glycolysis ; Human Genetics ; Hyperphosphatemia ; Internal Medicine ; Kidney diseases ; Mineralization ; Mitochondria ; Molecular Medicine ; Original ; Original Article ; Oxidative stress ; Phenotypes ; Respiration ; Smooth muscle</subject><ispartof>Journal of molecular medicine (Berlin, Germany), 2020-07, Vol.98 (7), p.985-997</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-605c7ae72cd7fe13bb169f95baf8fc60c0f04426c66c9410ea0daa229879b793</citedby><cites>FETCH-LOGICAL-c451t-605c7ae72cd7fe13bb169f95baf8fc60c0f04426c66c9410ea0daa229879b793</cites><orcidid>0000-0002-2145-3653</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00109-020-01925-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00109-020-01925-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,778,782,883,27911,27912,41475,42544,51306</link.rule.ids></links><search><creatorcontrib>Alesutan, Ioana</creatorcontrib><creatorcontrib>Moritz, Franco</creatorcontrib><creatorcontrib>Haider, Tatjana</creatorcontrib><creatorcontrib>Shouxuan, Sun</creatorcontrib><creatorcontrib>Gollmann-Tepeköylü, Can</creatorcontrib><creatorcontrib>Holfeld, Johannes</creatorcontrib><creatorcontrib>Pieske, Burkert</creatorcontrib><creatorcontrib>Lang, Florian</creatorcontrib><creatorcontrib>Eckardt, Kai-Uwe</creatorcontrib><creatorcontrib>Heinzmann, Silke Sophie</creatorcontrib><creatorcontrib>Voelkl, Jakob</creatorcontrib><title>Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells</title><title>Journal of molecular medicine (Berlin, Germany)</title><addtitle>J Mol Med</addtitle><description>In chronic kidney disease, hyperphosphatemia is a key pathological factor promoting medial vascular calcification, a common complication associated with cardiovascular events and mortality. This active pathophysiological process involves osteo-/chondrogenic transdifferentiation of vascular smooth muscle cells (VSMCs) via complex intracellular mechanisms that are still incompletely understood. Little is known about the effects of phosphate on the bioenergetic profile of VSMCs during the onset of this process. Therefore, the present study explored the effects of the phosphate donor β-glycerophosphate on cellular bioenergetics of VSMCs. Mitochondrial and glycolytic functions were determined utilizing extracellular flux analysis in primary human aortic VSMCs following exposure to β-glycerophosphate. In VSMCs, β-glycerophosphate increased basal respiration, mitochondrial ATP production as well as proton leak and decreased spare respiratory capacity and coupling efficiency, but did not modify non-mitochondrial or maximal respiration. β-Glycerophosphate-treated VSMCs had higher ability to increase mitochondrial glutamine and long-chain fatty acid usage as oxidation substrates to meet their energy demand. β-Glycerophosphate did not modify glycolytic function or basal and glycolytic proton efflux rate. In contrast, β-glycerophosphate increased non-glycolytic acidification. β-Glycerophosphate-treated VSMCs had a more oxidative and less glycolytic phenotype, but a reduced ability to respond to stressed conditions via mitochondrial respiration. Moreover, compounds targeting components of mitochondrial respiration modulated β-glycerophosphate-induced oxidative stress, osteo-/chondrogenic signalling and mineralization of VSMCs. In conclusion, β-glycerophosphate modifies key parameters of mitochondrial function and cellular bioenergetics in VSMCs that may contribute to the onset of phenotypical transdifferentiation and calcification. These observations advance the understanding of the role of energy metabolism in VSMC physiology and pathophysiology of vascular calcification during hyperphosphatemia.
Key messages
β-Glycerophosphate modifies key parameters of mitochondrial respiration in VSMCs.
β-Glycerophosphate induces changes in mitochondrial fuel choice in VSMCs.
β-Glycerophosphate promotes a more oxidative and less glycolytic phenotype of VSMCs.
β-Glycerophosphate triggers mitochondrial-dependent oxidative stress in VSMCs.
Bioenergetics impact β-glycerophosphate-induced VSMC calcification.</description><subject>Acidification</subject><subject>Aorta</subject><subject>b-Glycerophosphoric acid</subject><subject>Bioenergetics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Calcification</subject><subject>Calcification (ectopic)</subject><subject>Cardiovascular diseases</subject><subject>Electron transport</subject><subject>Energy metabolism</subject><subject>Glutamine</subject><subject>Glycolysis</subject><subject>Human Genetics</subject><subject>Hyperphosphatemia</subject><subject>Internal Medicine</subject><subject>Kidney diseases</subject><subject>Mineralization</subject><subject>Mitochondria</subject><subject>Molecular Medicine</subject><subject>Original</subject><subject>Original Article</subject><subject>Oxidative stress</subject><subject>Phenotypes</subject><subject>Respiration</subject><subject>Smooth muscle</subject><issn>0946-2716</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc9q3DAQh0VoSLZJXiAnQ89KR38sWZdCCG0TWOgll5yErB2tvdiWK9kLea0-SJ-p3uzS0EtPc5jv983Aj5BbBncMQH_OAAwMBQ4UmOElrc7IiknBKZMSPpAVGKko10xdko857xZcl0ZekEvBZVWVUq3Iy1M_Oj8VMRS_f9Ft9-oxxbGJeWzchEUciqnBom4jDpi2OLW-GFMMbYeHyN5lP3cuFbmPcWqKfs5-2XjsunxNzoPrMt6c5hV5_vb1-eGRrn98f3q4X1MvSzZRBaXXDjX3Gx2QibpmygRT1i5UwSvwEEBKrrxS3kgG6GDjHOem0qbWRlyRL0ftONc9bjwOU3KdHVPbu_Rqo2vtv5uhbew27q0WUmhRLYJPJ0GKP2fMk93FOQ3Ly5ZLzrgsBfCF4kfKp5hzwvD3AgN7aMMe27BLG_atDXtQi2MoL_CwxfSu_k_qDznnjkA</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Alesutan, Ioana</creator><creator>Moritz, Franco</creator><creator>Haider, Tatjana</creator><creator>Shouxuan, Sun</creator><creator>Gollmann-Tepeköylü, Can</creator><creator>Holfeld, Johannes</creator><creator>Pieske, Burkert</creator><creator>Lang, Florian</creator><creator>Eckardt, Kai-Uwe</creator><creator>Heinzmann, Silke Sophie</creator><creator>Voelkl, Jakob</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2145-3653</orcidid></search><sort><creationdate>20200701</creationdate><title>Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells</title><author>Alesutan, Ioana ; Moritz, Franco ; Haider, Tatjana ; Shouxuan, Sun ; Gollmann-Tepeköylü, Can ; Holfeld, Johannes ; Pieske, Burkert ; Lang, Florian ; Eckardt, Kai-Uwe ; Heinzmann, Silke Sophie ; Voelkl, Jakob</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-605c7ae72cd7fe13bb169f95baf8fc60c0f04426c66c9410ea0daa229879b793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acidification</topic><topic>Aorta</topic><topic>b-Glycerophosphoric acid</topic><topic>Bioenergetics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Calcification</topic><topic>Calcification (ectopic)</topic><topic>Cardiovascular diseases</topic><topic>Electron transport</topic><topic>Energy metabolism</topic><topic>Glutamine</topic><topic>Glycolysis</topic><topic>Human Genetics</topic><topic>Hyperphosphatemia</topic><topic>Internal Medicine</topic><topic>Kidney diseases</topic><topic>Mineralization</topic><topic>Mitochondria</topic><topic>Molecular Medicine</topic><topic>Original</topic><topic>Original Article</topic><topic>Oxidative stress</topic><topic>Phenotypes</topic><topic>Respiration</topic><topic>Smooth muscle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alesutan, Ioana</creatorcontrib><creatorcontrib>Moritz, Franco</creatorcontrib><creatorcontrib>Haider, Tatjana</creatorcontrib><creatorcontrib>Shouxuan, Sun</creatorcontrib><creatorcontrib>Gollmann-Tepeköylü, Can</creatorcontrib><creatorcontrib>Holfeld, Johannes</creatorcontrib><creatorcontrib>Pieske, Burkert</creatorcontrib><creatorcontrib>Lang, Florian</creatorcontrib><creatorcontrib>Eckardt, Kai-Uwe</creatorcontrib><creatorcontrib>Heinzmann, Silke Sophie</creatorcontrib><creatorcontrib>Voelkl, Jakob</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alesutan, Ioana</au><au>Moritz, Franco</au><au>Haider, Tatjana</au><au>Shouxuan, Sun</au><au>Gollmann-Tepeköylü, Can</au><au>Holfeld, Johannes</au><au>Pieske, Burkert</au><au>Lang, Florian</au><au>Eckardt, Kai-Uwe</au><au>Heinzmann, Silke Sophie</au><au>Voelkl, Jakob</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells</atitle><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle><stitle>J Mol Med</stitle><date>2020-07-01</date><risdate>2020</risdate><volume>98</volume><issue>7</issue><spage>985</spage><epage>997</epage><pages>985-997</pages><issn>0946-2716</issn><eissn>1432-1440</eissn><abstract>In chronic kidney disease, hyperphosphatemia is a key pathological factor promoting medial vascular calcification, a common complication associated with cardiovascular events and mortality. This active pathophysiological process involves osteo-/chondrogenic transdifferentiation of vascular smooth muscle cells (VSMCs) via complex intracellular mechanisms that are still incompletely understood. Little is known about the effects of phosphate on the bioenergetic profile of VSMCs during the onset of this process. Therefore, the present study explored the effects of the phosphate donor β-glycerophosphate on cellular bioenergetics of VSMCs. Mitochondrial and glycolytic functions were determined utilizing extracellular flux analysis in primary human aortic VSMCs following exposure to β-glycerophosphate. In VSMCs, β-glycerophosphate increased basal respiration, mitochondrial ATP production as well as proton leak and decreased spare respiratory capacity and coupling efficiency, but did not modify non-mitochondrial or maximal respiration. β-Glycerophosphate-treated VSMCs had higher ability to increase mitochondrial glutamine and long-chain fatty acid usage as oxidation substrates to meet their energy demand. β-Glycerophosphate did not modify glycolytic function or basal and glycolytic proton efflux rate. In contrast, β-glycerophosphate increased non-glycolytic acidification. β-Glycerophosphate-treated VSMCs had a more oxidative and less glycolytic phenotype, but a reduced ability to respond to stressed conditions via mitochondrial respiration. Moreover, compounds targeting components of mitochondrial respiration modulated β-glycerophosphate-induced oxidative stress, osteo-/chondrogenic signalling and mineralization of VSMCs. In conclusion, β-glycerophosphate modifies key parameters of mitochondrial function and cellular bioenergetics in VSMCs that may contribute to the onset of phenotypical transdifferentiation and calcification. These observations advance the understanding of the role of energy metabolism in VSMC physiology and pathophysiology of vascular calcification during hyperphosphatemia.
Key messages
β-Glycerophosphate modifies key parameters of mitochondrial respiration in VSMCs.
β-Glycerophosphate induces changes in mitochondrial fuel choice in VSMCs.
β-Glycerophosphate promotes a more oxidative and less glycolytic phenotype of VSMCs.
β-Glycerophosphate triggers mitochondrial-dependent oxidative stress in VSMCs.
Bioenergetics impact β-glycerophosphate-induced VSMC calcification.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>32488546</pmid><doi>10.1007/s00109-020-01925-8</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-2145-3653</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0946-2716 |
ispartof | Journal of molecular medicine (Berlin, Germany), 2020-07, Vol.98 (7), p.985-997 |
issn | 0946-2716 1432-1440 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7343738 |
source | Springer Nature - Complete Springer Journals |
subjects | Acidification Aorta b-Glycerophosphoric acid Bioenergetics Biomedical and Life Sciences Biomedicine Calcification Calcification (ectopic) Cardiovascular diseases Electron transport Energy metabolism Glutamine Glycolysis Human Genetics Hyperphosphatemia Internal Medicine Kidney diseases Mineralization Mitochondria Molecular Medicine Original Original Article Oxidative stress Phenotypes Respiration Smooth muscle |
title | Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T13%3A47%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20%CE%B2-glycerophosphate%20on%20the%20bioenergetic%20profile%20of%20vascular%20smooth%20muscle%20cells&rft.jtitle=Journal%20of%20molecular%20medicine%20(Berlin,%20Germany)&rft.au=Alesutan,%20Ioana&rft.date=2020-07-01&rft.volume=98&rft.issue=7&rft.spage=985&rft.epage=997&rft.pages=985-997&rft.issn=0946-2716&rft.eissn=1432-1440&rft_id=info:doi/10.1007/s00109-020-01925-8&rft_dat=%3Cproquest_pubme%3E2421245302%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2421245302&rft_id=info:pmid/32488546&rfr_iscdi=true |